semaglutide cardiovascular outcomes news of and tirzepatide for patients with type 2 diabetes in clinical practice semaglutide cardiovascular outcomes study 2025

This guide explains how they work in theory, known risks, evidence gaps, and how they compare to approved GLP-1 therapies.

Structural insights into the triple agonism at GLP-1R, GIPR and GCGR manifested by retatrutide

Startups are raising millions to build businesses around drugs like Ozempic and Wegovy, as they chase a market set to surge to $90 billion.

Emgality (Galcanezumab-gnlm Injection) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health resources.

In an attempt to compensate for the loss, other pathways are upregulated, e.g., the increased use of ketones produced from fatty acids by astrocytes that are shuttled to neurons

A well...